Peru Sessions 2023

Held on November 16 and 17, 2023 in the Good Hope Clinic Auditorium, Lima, Peru!

The XLVII SOLACI 2023 Regional Sessions (16th Andean Region) was held in Lima, Peru and presented a high-level scientific program with important national and Latin American guests who shared their knowledge and experiences over two days of intense academic activity

The Peru Sessions 2023 were organized by SOLACI together with the Peruvian Society of Hemodynamics and Endovascular Interventionism (SOPHIE), and was aimed at interventional cardiologists, clinical cardiologists, technicians and nurses in hemodynamics, and anyone who wanted to update and grow professionally.

We thank the local scientific society for its invaluable contribution to holding these Sessions, the medical industry and all the attendees who were part of this important event.


Discover the best contents of the Peru 2023 Conference



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
Next article

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...